Pinto, Y. & Bhatt, A. S. Sequencing-based analysis of microbiomes. Nat. Rev. Genet. 25, 829–845 (2024).
Sorbara, M. T. & Pamer, E. G. Microbiome-based therapeutics. Nat. Rev. Microbiol. 20, 365–380 (2022).
Zheng, D. P., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492–506 (2020).
Sender, R. & Milo, R. The distribution of cellular turnover in the human body. Nat. Med. 27, 45–48 (2021).
Patankar, J. V. & Becker, C. Cell death in the gut epithelium and implications for chronic inflammation. Nat. Rev. Gastroenterol. Hepatol. 17, 543–556 (2020).
Halpern, K. B. et al. The cellular states and fates of shed intestinal cells. Nat. Metab. 5, 1858–1869 (2023).
Mizoguchi, A. Animal models of inflammatory bowel disease. Prog. Mol. Biol. Transl. Sci. 105, 263–320 (2012).
Jurjus, A. R., Khoury, N. N. & Reimund, J. M. Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 50, 81–92 (2004).
Feuerstein, J. D. et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology 158, 1450–1461 (2020).
Feuerstein, J. D. et al. AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease. Gastroenterology 160, 2496–2508 (2021).
Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298–306 (2011).
Chang, J. T. Pathophysiology of inflammatory bowel diseases. N. Engl. J. Med. 383, 2652–2664 (2020).
Henry, J. B. in Clinical Diagnosis by Laboratory Methods 16th edn (ed. Henry, J. B.) Ch. 25 (Saunders, 1979).
Albaugh, G. P. et al. Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers. Int. J. Cancer 52, 347–350 (1992).
Imperiale, T. F. et al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 370, 1287–1297 (2014).
Jiang, P., Lai, S., Wu, S., Zhao, X. M. & Chen, W. H. Host DNA contents in fecal metagenomics as a biomarker for intestinal diseases and effective treatment. BMC Genomics 21, 348 (2020).
Reck, M. et al. Stool metatranscriptomics: a technical guideline for mRNA stabilisation and isolation. BMC Genomics 16, 494 (2015).
Rosa, F. et al. Transcriptional changes detected in fecal RNA of neonatal dairy calves undergoing a mild diarrhea are associated with inflammatory biomarkers. PLoS ONE 13, e0191599 (2018).
Knight, J. M. et al. Non-invasive analysis of intestinal development in preterm and term infants using RNA-sequencing. Sci. Rep. 4, 5453 (2014).
Ozsolak, F. & Milos, P. M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12, 87–98 (2011).
Ungar, B. et al. Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD. Gut 71, gutjnl-2021-325516 (2022).
Alexander, M. et al. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe 30, 17–30 (2022).
Federici, S. et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185, 2879–2898 (2022).
Sinha, S. R. et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 27, 659–670 (2020).
Vermeire, S., Van Assche, G. & Rutgeerts, P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55, 426–431 (2006).
Baker, S. C. et al. The External RNA Controls Consortium: a progress report. Nat. Methods 2, 731–734 (2005).
Rio, D. C., Ares, M. Jr, Hannon, G. J. & Nilsen, T. W. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb. Protoc. 2010, pdb prot5439 (2010).
Li, B. et al. A comprehensive mouse transcriptomic BodyMap across 17 tissues by RNA-seq. Sci. Rep. 7, 4200 (2017).
Chassaing, B., Aitken, J. D., Malleshappa, M. & Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol. 104, 15.25.11–15.25.14 (2014).
Mundy, R., MacDonald, T. T., Dougan, G., Frankel, G. & Wiles, S. Citrobacter rodentium of mice and man. Cell Microbiol. 7, 1697–1706 (2005).
Collins, J. W. et al. Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12, 612–623 (2014).
Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309–318 (2006).
Bauche, D. et al. LAG3+ regulatory T cells restrain interleukin-23-producing CX3CR1+ gut-resident macrophages during group 3 innate lymphoid cell-driven colitis. Immunity 49, 342–352 (2018).
Aden, K. et al. Epithelial IL-23R signaling licenses protective IL-22 responses in intestinal inflammation. Cell Rep. 16, 2208–2218 (2016).
Czarnewski, P. et al. Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification. Nat. Commun. 10, 2892 (2019).
Munoz, M. et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42, 321–331 (2015).
Palmieri, V. et al. Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity. Mucosal Immunol. 14, 923–936 (2021).
Kaser, A. et al. Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 24, 74–85 (2004).
Yao, Y. et al. Mucus sialylation determines intestinal host-commensal homeostasis. Cell 185, 1172–1188 (2022).
Sirvinskas, D. et al. Single-cell atlas of the aging mouse colon. iScience 25, 104202 (2022).
Ferrante, M. et al. Risankizumab as maintenance therapy for moderately to severely active Crohn’s disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial. Lancet 399, 2031–2046 (2022).
Langmann, T. et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127, 26–40 (2004).
Ajuebor, M. N., Kunkel, S. L. & Hogaboam, C. M. The role of CCL3/macrophage inflammatory protein-1α in experimental colitis. Eur. J. Pharmacol. 497, 343–349 (2004).
Dobre, M. et al. Mucosal gene expression as a marker of molecular activity in Crohn’s disease: preliminary data. Rom. J. Morphol. Embryo 58, 1263–1268 (2017).
Wang, H. et al. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis. Immunology 144, 254–262 (2015).
Ji, B. W., Sheth, R. U., Dixit, P. D., Tchourine, K. & Vitkup, D. Macroecological dynamics of gut microbiota. Nat. Microbiol. 5, 768–775 (2020).
Pathirana, W. G. W., Chubb, S. P., Gillett, M. J. & Vasikaran, S. D. Faecal calprotectin. Clin. Biochem. Rev. 39, 77–90 (2018).
Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–117 (2018).
Shin, J. H. et al. The gut peptide Reg3g links the small intestine microbiome to the regulation of energy balance, glucose levels, and gut function. Cell Metab. 34, 1765–1778 (2022).
Raffals, L. E. et al. The development and initial findings of a Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflamm. Bowel Dis. 28, 192–199 (2022).
Waldman, S. A. & Camilleri, M. Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut 67, 1543–1552 (2018).
West, N. R. et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat. Med. 23, 579–589 (2017).
Golob, J. et al. The microbiome in quiescent Crohn’s disease with persistent symptoms show disruptions in microbial sulfur and tryptophan pathways. Gastro. Hep. Adv. 3, 167–177 (2024).
Fellmann, F., Pretet, J. L. & Fellmann, D. Simplified protocol of solid-phase cDNA libraries for multiple PCR amplification. Biotechniques 21, 766, 768, 770 (1996).
Raineri, I., Moroni, C. & Senn, H. P. Improved efficiency for single-sided PCR by creating a reusable pool of first-strand cDNA coupled to a solid phase. Nucleic Acids Res. 19, 4010 (1991).
Hu, L. L. et al. m6A RNA modifications are measured at single-base resolution across the mammalian transcriptome. Nat. Biotechnol. 40, 1210–1219 (2022).
Liu, C. et al. Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat. Biotechnol. 41, 355–366 (2023).
Dai, Q. et al. Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. Nat. Biotechnol. 41, 344–354 (2023).
Ota, M. et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 184, 3006–3021 (2021).
Soskic, B. et al. Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation. Nat. Genet. 54, 817–826 (2022).
Owczarzy, R. et al. IDT SciTools: a suite for analysis and design of nucleic acid oligomers. Nucleic Acids Res. 36, W163–W169 (2008).
Xie, N. G. et al. Designing highly multiplex PCR primer sets with Simulated Annealing Design using Dimer Likelihood Estimation (SADDLE). Nat. Commun. 13, 1881 (2022).
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 3 (2011).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–354 (2012).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
Ji, B. W. et al. Quantifying spatiotemporal variability and noise in absolute microbiota abundances using replicate sampling. Nat. Methods 16, 731–736 (2019).
Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Micro. 73, 5261–5267 (2007).
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).
